BLEPHARITIS TREATMENT MARKET ANALYSIS
Furthermore, adoption of strategies such as new product launch and mergers and acquisitions is also expected to contribute to the market growth. For instance, in 2015, Rysurg, a Franklin-based company, launched BlephEx. It is the first device-based procedure used to clean eyelids and also maintain hygiene. According to a study conducted by American Academy of Ophthalmology in 2015, around 50% of ophthalmic patients suffer from symptoms of blepharitis and dry eyes. Constant use of this device helps prevent recurrence of blephairis and the treatment is pain-free. In 2013, Shire Plc. acquired a U.S.-based ophthalmic company, SARcode Bioscience to add new drug – Lifitegrast to Shire’s specialist drug portfolio. Lifitegrast was approved by the U.S. FDA for the treatment of signs and symptoms of dry eye and blepharitis in 2016.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 